Manuscript Categories
Neurology: Clinical Practice (NCP) is not currently indexed in MEDLINE. Complete NCP articles are available (using the PubMed search) in PubMed Central (PMC) one year after publication. Abstracts of more current NCP articles are delivered to PMC after they have been published in an issue (6 issues per year). Abstracts (which link to the full article on the Neurology: Clinical Practice website) should be searchable by PubMed within a few weeks. NCP is indexed in Embase, Scopus, CrossRef, Google Scholar, and Emerging Sources Citation Index.
Neurology: Clinical Practice
|
Article type |
Characteristics |
Requirements |
Policies |
|---|---|---|---|
|
Research |
Original contributions of direct relevance and importance to clinical practice. We will consider: prospective, observational and retrospective studies, meta-analyses and drug trials. |
|
|
|
Case Report |
IMPORTANT: Most Case Reports will be published on-line only. Case Reports published on-line will be listed on the Table of Contents of a print issue. Case reports should be concise and focus on unique manifestations or new observations of a clinical case. A good case report for practitioners should be unusual and informative to mechanism or educational and narrative. Evidence should be referenced from high quality studies, and discussion should concentrate on the risks and benefits in an individual patient (preferences, particular circumstances). Reports of clinical cases must have a clear message that might influence clinical practice. |
|
|
|
Short Case |
|
||
|
Review Article |
Comprehensive, scholarly and balanced articles that present an expert examination of literature on a topic. We will consider: systematic reviews, meta-analyses and non-systematic/narrative reviews. Case reports or clinical vignettes used to illustrate a clinical approach or investigations/diagnosis/treatment to a challenging clinical or ethical presentation and accompanied by a comprehensive review of the literature should be submitted as a Review Article. Review Articles should comment on the quality of the available evidence and draw from the author’s practical experience about situations not covered by available evidence. Some Review Articles are invited, but the editors welcome unsolicited submissions and suggestions of topics/authors for consideration. |
|
|
|
Five New Things |
These articles are up-to-date reviews of recent findings in fields such as Parkinson disease, multiple sclerosis, gliomas and stroke. |
|
|
|
Drugs and Devices |
Drugs and Devices articles are reviews of recent advancements and timely issues concerning diagnostic tools and emerging therapies. |
|
|
|
Commentary |
Timely analysis of current advances and insights into future directions of recent research findings, health policy issues, or practice management concerns of broad interest to clinical practice (e.g. diagnostic, therapeutic, political, social, ethical, economic, career, etc.) Where possible, authors should strive to make the material relevant to international readers as well as U.S. neurologists. Some Commentaries are invited, but the editors welcome unsolicited submissions and suggestions of topics/authors for consideration. |
|
Neurology: Neuroimmunology & Neuroinflammation
|
Article type |
Characteristics |
Requirements |
Policies |
|---|---|---|---|
|
Article |
Articles are full-length reports of original research. These include large-scale pivotal trials of new therapies (randomized clinical trials). The WHO's definition of a clinical trial that was adopted by the International Committee of Medical Journal Editors (ICMJE): "[a clinical trial is]…any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators. |
|
|
|
Articles (Smaller Scope Studies) |
Neurology: Neuroimmunology & Neuroinflammation will consider smaller (e.g., 10-50 participants), uncontrolled, nonrandomized, or unblinded clinical trials as Articles. This category includes preliminary observations or pilot studies or presentation of one or a few informative cases. These manuscripts should be uploaded under "Article" in the Neurology: Neuroimmunology & Neuroinflammation tracking system. Editors will make final decisions regarding length of these articles. |
|
|
|
Clinical/Scientific Note |
Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies. |
|
|
|
Views & Reviews |
Views & Reviews are either a review or an opinion statement that provides a summary of the most important recent information on a topic. If the Review summarizes recommendations for practice, use the word "Recommendations" in the title rather than "Guidelines." (Guidelines published in the Journal are created by an established process by the American Academy of Neurology.) |
|
|
|
Diagnostic and Treatment Challenges |
This section features a classical case-report presentation and multidisciplinary discussion among physicians, with the aim to underscore the “pearls,” “pitfalls,” and fundamental principles that can be effectively integrated into practice. This educational offering will include cases selected from the Conference Webinars presented by the National Multiple Sclerosis Society Clinical Fellows and other submissions from readers of similarly formulated case reports and discussions from forums such as grand rounds or multidisciplinary conferences. Cases will include patients with any type of neuroimmunologic disease. |
|
|
|
Letters |
The goal of this section is to encourage concise, rapid debate among authors and readers of Neurology: Neuroimmunology & Neuroinflammation Letters are restricted to comments about studies published in Neurology: Neuroimmunology & Neuroinflammation within the past two issues, with the exception of submissions identifying possible errors in data or data analysis or by appeal to the Editor. The letters will be edited for clarity and length. Readers wishing to submit a letter should access the article and click on "Comment" in the box at the top of the page. Letters are not indexed by PubMed. |
|
Authors of letters should keep the following statement from the Uniform Requirements for Medical Journal Editors in mind: "Although editors have the prerogative to sift out correspondence material that is irrelevant, uninteresting, or lacking in cogency, they have a responsibility to allow a range of opinion to be expressed. The correspondence column should not be used merely to promote the Journal's or the editors' point of view. In all instances, editors must make an effort to screen out discourteous, inaccurate, or libelous statements, and should not allow ad hominem arguments intended to discredit opinions or findings." |
Neurology: Genetics
|
Article type |
Characteristics |
Requirements |
Policies |
|---|---|---|---|
|
Article |
Articles are full-length reports of original research. These include large-scale pivotal trials of new therapies (randomized clinical trials). The WHO's definition of a clinical trial that was adopted by the International Committee of Medical Journal Editors (ICMJE): "[a clinical trial is]…any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators. |
|
|
|
Articles (Smaller Scope Studies) |
Neurology: Genetics will consider smaller (e.g., 10-50 participants), uncontrolled, nonrandomized, or unblinded clinical trials as Articles. This category includes preliminary observations or pilot studies or presentation of one or a few informative cases. These manuscripts should be uploaded under "Article" in the Neurology: Genetics tracking system. Editors will make final decisions regarding length of these articles. |
|
|
|
Clinical/Scientific Note |
Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies. |
|
|
|
Views & Reviews |
Views & Reviews are either a review or an opinion statement that provides a summary of the most important recent information on a topic. If the Review summarizes recommendations for practice, use the word "Recommendations" in the title rather than "Guidelines." (Guidelines published in the Journal are created by an established process by the American Academy of Neurology.) |
|
|
|
NeuroImages or Video NeuroImages |
Submissions include photomicrographs, photographs, neuroradiologic images, and videos. |
|
|
|
Letters |
The goal of this section is to encourage concise, rapid debate among authors and readers of Neurology: Genetics Letters are restricted to comments about studies published in Neurology: Genetics within the past two issues, with the exception of submissions identifying possible errors in data or data analysis or by appeal to the Editor. The letters will be edited for clarity and length. Readers wishing to submit a letter can access the article and click on "Comment" in the box on the top of the article page. Letters are not indexed by PubMed. |
|
Authors of letters should keep the following statement from the Uniform Requirements for Medical Journal Editors in mind: "Although editors have the prerogative to sift out correspondence material that is irrelevant, uninteresting, or lacking in cogency, they have a responsibility to allow a range of opinion to be expressed. The correspondence column should not be used merely to promote the Journal's or the editors' point of view. In all instances, editors must make an effort to screen out discourteous, inaccurate, or libelous statements, and should not allow ad hominem arguments intended to discredit opinions or findings." |